Join
Live feed
·
PRReleasevia Quantisnow
DSS Inc. logo
Impact BioMedical Inc. logo

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth

ByQuantisnow·Wall Street's wire, on your screen.
DSS· DSS Inc.IBO· Impact BioMedical Inc.
Consumer DiscretionaryHealth Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DSS (DSS Inc.), IBO (Impact BioMedical Inc.) and more on Quantisnow.

DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth | Quantisnow